185 related articles for article (PubMed ID: 9751617)
1. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?
Neumann E; Engelsberg A; Decker J; Störkel S; Jaeger E; Huber C; Seliger B
Cancer Res; 1998 Sep; 58(18):4090-5. PubMed ID: 9751617
[TBL] [Abstract][Full Text] [Related]
2. 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
Coral S; Sigalotti L; Altomonte M; Engelsberg A; Colizzi F; Cattarossi I; Maraskovsky E; Jager E; Seliger B; Maio M
Clin Cancer Res; 2002 Aug; 8(8):2690-5. PubMed ID: 12171902
[TBL] [Abstract][Full Text] [Related]
3. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.
Syed ON; Mandigo CE; Killory BD; Canoll P; Bruce JN
J Clin Neurosci; 2012 Jul; 19(7):1016-21. PubMed ID: 22534618
[TBL] [Abstract][Full Text] [Related]
4. mRNA expression of tumor-associated antigens in melanoma tissues and cell lines.
Eichmüller S; Usener D; Jochim A; Schadendorf D
Exp Dermatol; 2002 Aug; 11(4):292-301. PubMed ID: 12190937
[TBL] [Abstract][Full Text] [Related]
5. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S
Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
Pan SH; Su KY; Spiessens B; Kusuma N; Delahaye NF; Gruselle O; Myo A; de Creus A; Louahed J; Chang GC; Yu SL; Yang PC
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e212-e223. PubMed ID: 27519286
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Thongprasert S; Yang PC; Lee JS; Soo R; Gruselle O; Myo A; Louahed J; Lehmann FF; Brichard VG; Coche T
Lung Cancer; 2016 Nov; 101():137-144. PubMed ID: 27794402
[TBL] [Abstract][Full Text] [Related]
9. Expression of MAGE genes in renal cell carcinoma.
Yamanaka K; Miyake H; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Mol Med; 1998 Jul; 2(1):57-60. PubMed ID: 9854143
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma.
Dannenmann SR; Hermanns T; Bransi A; Matter C; von Boehmer L; Stevanovic S; Schraml P; Moch H; Knuth A; van den Broek M
Cancer Immunol Res; 2013 Nov; 1(5):288-95. PubMed ID: 24777966
[TBL] [Abstract][Full Text] [Related]
11. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
Pellat-Deceunynck C; Mellerin MP; Labarrière N; Jego G; Moreau-Aubry A; Harousseau JL; Jotereau F; Bataille R
Eur J Immunol; 2000 Mar; 30(3):803-9. PubMed ID: 10741395
[TBL] [Abstract][Full Text] [Related]
12. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
13. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.
Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A
Oncology; 2003; 64(4):443-9. PubMed ID: 12759544
[TBL] [Abstract][Full Text] [Related]
14. Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study.
Forchhammer S; Pop OT; Hahn M; Aebischer V; Seitz CM; Schroeder C; Liebmann A; Abele M; Wild H; Bien E; Kunc M; Schneider DT; Cuk K; Büttel I; Flemmig C; Peters M; Laible M; Brück P; Türeci Ö; Sahin U; Flatz L; Brecht IB
Virchows Arch; 2024 Jun; ():. PubMed ID: 38890171
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
[TBL] [Abstract][Full Text] [Related]
16. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
Stockert E; Jäger E; Chen YT; Scanlan MJ; Gout I; Karbach J; Arand M; Knuth A; Old LJ
J Exp Med; 1998 Apr; 187(8):1349-54. PubMed ID: 9547346
[TBL] [Abstract][Full Text] [Related]
17. Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.
Luyten GP; van der Spek CW; Brand I; Sintnicolaas K; de Waard-Siebinga I; Jager MJ; de Jong PT; Schrier PI; Luider TM
Melanoma Res; 1998 Feb; 8(1):11-6. PubMed ID: 9508371
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.
Cormier JN; Abati A; Fetsch P; Hijazi YM; Rosenberg SA; Marincola FM; Topalian SL
J Immunother; 1998 Jan; 21(1):27-31. PubMed ID: 9456433
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-associated antigens recognized by cytotoxic T lymphocytes.
Kirkin AF; Dzhandzhugazyan K; Zeuthen J
APMIS; 1998 Jul; 106(7):665-79. PubMed ID: 9740504
[TBL] [Abstract][Full Text] [Related]
20. NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.
Giesen E; Jilaveanu LB; Parisi F; Kluger Y; Camp RL; Kluger HM
Oncotarget; 2014 Jul; 5(14):5209-17. PubMed ID: 24970819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
